Emerging role of innate immunity in organ transplantation Part II: Potential of damage-associated molecular patterns to generate immunostimulatory dendritic cells

Transplantation Reviews

Volumn 26, Issue 2, 2012, Pages 73-87

  Land, Walter G ^a  

^a German Academy for Transplantation Medicine   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CRYOPYRIN; HEAT SHOCK PROTEIN 72; HIGH MOBILITY GROUP B1 PROTEIN; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; IMMUNOGLOBULIN M ANTIBODY; INFLAMMASOME; INTERFERON; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NATURAL KILLER CELL RECEPTOR NKG2D; RANTES; SECONDARY LYMPHOID TISSUE CHEMOKINE; TUMOR NECROSIS FACTOR;

ADAPTIVE IMMUNITY; CELL ACTIVATION; CELL MATURATION; CYTOKINE RELEASE; DAMAGE ASSOCIATED MOLECULAR PATTERN; DENDRITIC CELL; GAMMA DELTA T LYMPHOCYTE; HISTOCOMPATIBILITY; HUMAN; IMMUNOSTIMULATION; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MOLECULAR BIOLOGY; NATURAL KILLER CELL; NONHUMAN; ORGAN TRANSPLANTATION; OXIDATIVE STRESS; PATTERN RECOGNITION; REVIEW; UPREGULATION;

EID: 84858999769     PISSN: 0955470X     EISSN: 15579816     Source Type: Journal    
DOI: 10.1016/j.trre.2011.02.003     Document Type: Review

References (86)

1. Land W.G. Emerging role of innate immunity in organ transplantation. Part I: evolution of innate immunity and oxidative allograft injury. Transplant Rev 2011.
2. Land W. Postischemic reperfusion injury to allografts: its impact on T-cell alloactivation via up-regulation of dendritic cell-mediated stimulation, co-stimulation, and adhesion. Curr Opin Organ Transpl 1999, 4:118-124.
3. Shoskes D.A., Parfrey N.A., Halloran P.F. Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation 1990, 49:201-207.
4. Takada M., Chandraker A., Nadeau K.C., Sayegh M.H., Tilney N.L. The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J Clin Invest 1997, 100:1199-1203.
5. Rutauld K., Alderman C., Chain B.M., Katz D.R. Reactive oxygen species activate human peripheral blood dendritic cells. Free Radic Biol Med 1998, 26:232-238.
6. Halliwell B., Gutteridge J.M.C. Free radicals in biology and medicine 2000, Oxford University Press, Oxford, UK. 3rd ed.
7. Land W.G. Innate alloimmunity. Part 2. Innate immunity and allograft rejection 2011, Başkent University - Pabst Science Publishers, Ankara, Turkey.
8. Zhai Y., Shen X.D., O'Connell R., et al. TLR4 activation mediates liver ischemia/reperfusion inflammatory response via INF regulatory factor 3-dependent, MyD88-independent pathway. J Immunol 2004, 173:7115-7119.
9. Tsung A., Hoffman R.A., Izuishi K., et al. Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol 2005, 175:7661-7668.
10. Leemans J.C., Stokman G., Claessen N., et al. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 2005, 115:2894-2903.
11. Volz H.C., Kaya Z., Katus H.A., Andrassy M. The role of HMGB1/RAGE in inflammatory cardiomyopathy. Semin Thromb Hemost 2010, 36:185-194.
12. Manfredi A.A., Capobianco A., Bianchi M.E., Rovere-Querini P. Regulation of dendritic- and T-cell fate by injury-associated endogenous signals. Crit Rev Immunol 2009, 29:69-86.
13. Rovere-Querini P., Capobianco A., Scaffidi P., et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 2004, 5:825-830.
14. Messmer D., Yang H., Telsuma G., et al. High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J Immunol 2004, 173:307-313.
15. Yang D., Chen Q., Yang H., Tracey K.J., Bustin M., Oppenheim J.J. High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol 2007, 81:59-66.
16. Zhu X.M., Yao Y.M., Liang H.P., et al. The effect of high mobility group box-1 protein on splenic dendritic cell maturation in rats. J Interferon Cytokine Res 2009, 29:677-686.
17. Land W. Allograft injury mediated by reactive oxygen species: from conserved proteins of Drosophila to acute and chronic rejection of human transplants. Part II: role of reactive oxygen species in the induction of the heat shock response as a regulator of innate immunity. Transplant Rev 2003, 17:31-44.
18. Arbogast H., Arbogast S., Fertmann J., et al. Expression of heat shock proteins in cadaveric human renal allografts-a role in activation of innate immunity?. Transplantation 2002, 74(Suppl):266.
19. Bethke K., Staib F., Distler M., et al. Different efficiency of heat shock proteins (HSP) to activate human monocytes and dendritic cells: superiority of HSP60. J Immunol 2002, 169:6141-6148.
20. Ashtekar A.R., Zhang P., Katz J., et al. TLR4-mediated activation of dendritic cells by the heat shock protein DnaK from Francisella tularensis. J Leukoc Biol 2008, 84:1434-1446.
21. Jurewicz M., Takakura A., Augello A., et al. Ischemic injury enhances dendritic cell immunogenicity via TLR4 and NF-kappa B activation. J Immunol 2010, 184:2939-2948.
22. Termeer C., Benedix F., Sleeman J., et al. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002, 195:99-111.
23. Johnson G.B., Brunn G.J., Kodaira Y., Platt J.L. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 2002, 168:5233-5239.
24. Champsaur M., Lanier L.L. Effect of NKG2D ligand expression on host immune responses. Immunol Rev 2010, 235:267-285.
25. He Y., Li Y.P., Li S.F., Long D. Effect of hypoxia/reoxygenation (H/R) on expression of MICA and MICB in human hepatocytes. Sichuan Da Xue Xue Bao Yi Xue Ban 2005, 36:157-160.
26. Borchers M.T., Harris N.L., Wesselkamper S.C., Vitucci M., Cosman D. NKG2D ligands are expressed on stressed human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2006, 291:L222-L2231.
27. Feng L., Cheng F., Ye Z., et al. The effect of renal ischemia-reperfusion injury on expression of RAE-1 and H60 in mice kidney. Transplant Proc 2006, 38:2195-2198.
28. Ascon D.B., Lopez-Briones S., Liu M., et al. Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury. J Immunol 2006, 177:3380-3387.
29. Li L., Huang L., Sung S.S., et al. NKT cell activation mediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury. J Immunol 2007, 178:5899-5911.
30. Lappas C.M., Day Y.J., Marshall M.A., Engelhard V.H., Linden J. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. J Exp Med 2006, 203:2639-2648.
31. Savransky V., Molls R.R., Burne-Taney M., Chien C.C., Racusen L., Rabb H. Role of the T-cell receptor in kidney ischemia-reperfusion injury. Kidney Int 2006, 69:233-238.
32. Hochegger K., Schätz T., Eller P., et al. Role of alpha/beta and gamma/delta T cells in renal ischemia reperfusion injury. Am J Physiol Renal Physiol 2007, 293:F741-F747.
33. Schlitt H.J., Raddatz G., Steinhoff G., Wonigeit K., Pichlmayr R. Passenger lymphocytes in human liver allografts and their potential role after transplantation. Transplantation 1993, 56:951-955.
34. Navarro F., Portales P., Candon S., et al. Natural killer cell and alphabeta and gammadelta lymphocyte traffic into liver graft immediately after liver transplantation. Transplantation 2000, 69:633-639.
35. Quiroga I., Salio M., Koo D.D., et al. Expression of MHC class I-related chain B (MICB) molecules on renal transplant biopsies. Transplantation 2006, 81:1196-1203.
36. Munz C.h., Steinman R.M., Fujii S.I. Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J Exp Med 2005, 202:203-207.
37. Zitvogel L., Terme M., Borg C., Trinchieri G. Dendritic cell-NK cell cross-talk: regulation and physiopathology. Curr Top Microbiol Immunol 2006, 298:157-174.
38. Reschner A., Hubert P., Delvenne P., Boniver J., Jacobs N. Innate lymphocyte and dendritic cell crosstalk: a key factor in the regulation of the immune response. Clin Exp Immunol 2008, 152:219-226.
39. Martinon F., Mayor A., Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol 2009, 27:229-265.
40. Rock K.L., Latz E., Ontiveros F., Kono H. The sterile inflammatory response. Annu Rev Immunol 2010, 28:321-324.
41. Latz E. The inflammasomes: mechanisms of activation and function. Curr Opin Immunol 2010, 22:28-33.
42. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
43. Martinon F. Signaling by ROS drives inflammasome activation. Eur J Immunol 2010, 40:616-619.
44. Land W., Messmer K. The impact of ischemia/reperfusion injury on specific and non-specific, early and late chronic events after organ transplantation. Early events. Transplant Rev 1996, 10:108-127.
45. Wanderer A.A. Rationale and timeliness for IL-1beta-targeted therapy to reduce allogeneic organ injury at procurement and to diminish risk of rejection after transplantation. Clin Transplant 2010, 24:307-311.
46. Leslie J.A., Meldrum K.K. The role of interleukin-18 in renal injury. J Surg Res 2008, 145:170-175.
47. Iyer S., Pulskensc W., Sadler J., et al. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. PNAS 2009, 106:20388-20393.
48. Li H., Ambade A., Re F. Cutting edge: necrosis activates the NLRP3 inflammasome. J Immunol 2009, 183:1528-1532.
49. Babelova A., Moreth K., Tsalastra-Greul W., et al. Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J Biol Chem 2009, 284:24035-24048.
50. Yamasaki K., Muto J., Taylor K.R., et al. NLRP3/cryopyrin is necessary for interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. J Biol Chem 2009, 284:12762-12771.
51. Cassel S.L., Sutterwala F.S. Sterile inflammatory responses mediated by the NLRP3 inflammasome. Eur J Immunol 2010, 40:607-611.
52. Ghiringhelli F., Apetoh L., Tesniere A., et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 2009, 15:1170-1178.
53. Aymeric L., Apetoh L., Ghiringhelli F., et al. Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity. Cancer Res 2010, 70:855-858.
54. Zhou R., Tardivel A., Thorens B., Choi I., Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 2010, 11:136-140.
55. Bauernfeind F.G., Horvath G., Stutz A. Cutting edge: NFkappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 2009, 183:787-791.
56. Franchi L., Eigenbrod T., Nunez G. Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J Immunol 2009, 183:792-796.
57. Hornung V., Latz E. Critical functions of priming and lysosomal damage for NLRP3 activation. Eur J Immunol 2010, 40:620-623.
58. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994, 12:991-1045.
59. Land W., Schneeberger H., Schleibner S., et al. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 1994, 57:211-217.
60. Hornung V., Ablasser A., Charrel-Dennis M., et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009, 458:514-518.
61. Vilaysane A., Muruve D.A. The innate immune response to DNA. Semin Immunol 2009, 21:208-214.
62. Hornung V., Latz E. Intracellular DNA recognition. Nat Rev Immunol 2010, 10:123-130.
63. Rai P. Oxidation in the nucleotide pool, the DNA damage response and cellular senescence: Defective bricks build a defective house. Mutat Res 2010, 703:70-81.
64. Esposito L.A., Melov S., Panov A., Cottrell B.A., Wallace D.C. Mitochondrial disease in mouse results in increased oxidative stress. Proc Natl Acad Sci U S A 1999, 96:4820-4825.
65. Sun Z., Zhang X., Ito K., Montgomery R.A., Tachibana S., Williams G.M. Amelioration of oxidative mitochondrial DNA damage and deletion after renal ischemic injury by the KATP channel opener diazoxide. Am J Physiol Renal Physiol 2008, 294:F491-F498.
66. Sun K.H., Yu C.L., Tang S.J., Sun G.H. Monoclonal anti-double-stranded DNA autoantibody stimulates the expression and release of IL-1β, IL-6, IL-8, IL-10 and TNF-α from normal human mononuclear cells involving in the lupus pathogenesis. Immunology 2000, 99:352-360.
67. Winzler C., Rovere P., Rescigno M., et al. Maturation stages of mouse dendritic cells in growth factor dependent long-term cultures. J Exp Med 1997, 185:317-328.
68. Joffre O., Nolte M.A., Spörri R., Reis e Sousa C. Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol Rev 2009, 227:234-247.
69. Koulmanda M., Strom T.B. T-cell-directed treatment strategies for type 1 diabetes and the confounding role of inflammation. Immunotherapy 2010, 2:431-436.
70. Kong W., Yen J.H., Vassiliou E., Adhikary S., Toscano M.G., Ganea D. Docosahexaenoic acid prevents dendritic cell maturation and in vitro and in vivo expression of the IL-12 cytokine family. Lipids Health Dis 2010, 9:12.
71. Williams A., Flavell R.A., Eisenbarth S.C. The role of NOD-like receptors in shaping adaptive immunity. Curr Opin Immunol 2010, 22:34-40.
72. Meng G., Zhang F., Fuss I., Kitani A., Strober W. A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity 2009, 30:860-874.
73. Gris D., Ye Z., Iocca H.A., et al. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. J Immunol 2010, 185:974-981.
74. Zhang M., Carroll M.C. Natural IgM-mediated innate autoimmunity: a new target for early intervention of ischemia-reperfusion injury. Expert Opin Biol Ther 2007, 7:1-8.
75. Zhang M., Alicot E.M., Chiu I., et al. Identification of the target self-antigens in reperfusion injury. J Exp Med 2006, 203:141-152.
76. Chan R.K., Ibrahim S.I., Takahashi K., et al. The differing roles of the classical and mannose-binding lectin complement pathways in the events following skeletal muscle ischemia-reperfusion. J Immunol 2006, 177:8080-8085.
77. Lee H., Green D.J., Lai L., et al. Early complement factors in the local tissue immunocomplex generated during intestinal ischemia/reperfusion injury. Mol Immunol 2010, 47:972-981.
78. Kosieradzki M., Kuczynska J., Piwowarska J., et al. Prognostic significance of free radicals: mediated injury occurring in the kidney donor. Transplantation 2003, 75:1221-1227.
79. Krüger B., Krick S., Dhillon N., Lerner S.M., Ames S., Bromberg J.S., et al. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci U S A 2009, 106:3390-3395.
80. Takada M., Nadeau K.C., Hancock W.W., et al. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation 1998, 65:1533-1542.
81. Kusaka M., Pratschke J., Wilhelm M.J., et al. Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation 2000, 69:405-410.
82. Morariu A.M., Martins P.N., Leuvenink H.G., et al. Brain death and donor age synergistically accelerate the early immune response of allograft recipient (abstract # O155). Transpl Int 2007, 20:47.
83. Weiss S., Kotsch K., Francuski M., et al. Brain death activated donor organs and is associated with a worse I/R injury after liver transplantation. Am J Transplant 2007, 7:1584-1593.
84. Thomson A.W. Tolerogenic dendritic cells: all present and correct?. Am J Transplant 2010, 10:214-219.
85. + T cells by alternatively activated dendritic cells. J Leukoc Biol 2008, 84:124-133.
86. Kenna T.J., Thomas R., Steptoe R.J. Steady-state dendritic cells expressing cognate antigen terminate memory CD8+ T-cell responses. Blood 2008, 111:2091-2100.